Make Informed Investment Decisions with Affordable Access to Experts
Fridays with Adam Feuerstein #2 - Discussing Gottlieb, FOURIER data, and AF's Biotech Bear CaseTicker(s): AMGN, MDCO, IONS, REGN, AZN, AVXS, CLVS, TSRO, ALNY
Name: Adam Feuerstein
Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. A veteran journalist, Adam was most recently Senior Columnist at TheStreet, where he wrote about biotech and drug stocks. Adam lives near Boston with his wife, two kids and Bo, an insanely cute boxer/mutt.
Join now and add your questions for Adam F.!Added By: joe_mccann
Your opinion on BLCM?Added By: aklapholz
STML?Added By: biohunter
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.